Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator.
Andou
S
S
Fujii
S
S
Harada
Y
Y
Ooi
J
J
Nomiyama
J
J
Mori
K
K
Ookubo
M
M
Azuno
Y
Y
Fujii
Y
Y
Kaku
K
K
D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008750:Methyldopa / Q000009:adverse effects*; D008875:Middle Aged; D062367:ortho-Aminobenzoates / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D062367:ortho-Aminobenzoates; D008750:Methyldopa; C015735:lobenzarit